{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:13:30Z","timestamp":1792523610584,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the long-term safety and tolerability of a once-daily, dual-release hydrocortisone (DR-HC) tablet as oral glucocorticoid replacement therapy in patients with primary adrenal insufficiency (AI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective, open-label, multicenter, 5-year extension study of DR-HC conducted at five university clinics in Sweden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy-one adult patients diagnosed with primary AI who were receiving stable glucocorticoid replacement therapy were recruited. Safety and tolerability outcomes included adverse events (AEs), intercurrent illness episodes, laboratory parameters and vital signs. Quality of life (QoL) was evaluated using generic questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Total DR-HC exposure was 328 patient-treatment years. Seventy patients reported 1060 AEs (323 per 100 patient-years); 85% were considered unrelated to DR-HC by the investigator. The most common AEs were nasopharyngitis (70%), fatigue (52%) and gastroenteritis (48%). Of 65 serious AEs reported by 32 patients (20 per 100 patient-years), four were considered to be possibly related to DR-HC: acute AI (<jats:italic>n<\/jats:italic>\u2009=\u20092), gastritis (<jats:italic>n<\/jats:italic>\u2009=\u20091) and syncope (<jats:italic>n<\/jats:italic>\u2009=\u20091). Two deaths were reported (fall from height and subarachnoid hemorrhage), both considered to be unrelated to DR-HC. From baseline to 5 years, intercurrent illness episodes remained relatively stable (mean 2.6\u20135.4 episodes per patient per year), fasting plasma glucose (0.7\u2009mmol\/L;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and HDL cholesterol (0.2\u2009mmol\/L;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) increased and patient-\/investigator-assessed tolerability improved. QoL total scores were unchanged but worsening physical functioning was recorded (<jats:italic>P<\/jats:italic>\u2009=\u20090.008).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In the first prospective study evaluating the long-term safety of glucocorticoid replacement therapy in patients with primary AI, DR-HC was well tolerated with no safety concerns observed during 5-year treatment.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-17-0067","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:45:20Z","timestamp":1489538720000},"page":"715-725","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":34,"title":["Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study"],"prefix":"10.1093","volume":"176","author":[{"given":"Anna G","family":"Nilsson","sequence":"first","affiliation":[{"name":"1Department of EndocrinologySahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhildur","family":"Bergthorsdottir","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologySahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Burman","sequence":"additional","affiliation":[{"name":"2Department of EndocrinologySk\u00e5ne University Hospital Malm\u00f6, University of Lund, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"3Department of Public Health and Clinical MedicineUme\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Ekman","sequence":"additional","affiliation":[{"name":"4Departments of Endocrinology and Medical and Health SciencesLink\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt Ed\u00e9n","family":"Engstr\u00f6m","sequence":"additional","affiliation":[{"name":"5Department of Medical SciencesEndocrinology and Metabolism, University Hospital, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologySahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanko","family":"Skrtic","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologySahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"6AstraZeneca R&DM\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Wahlberg","sequence":"additional","affiliation":[{"name":"4Departments of Endocrinology and Medical and Health SciencesLink\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Achenbach","sequence":"additional","affiliation":[{"name":"7Shire International GmbHZug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif","family":"Uddin","sequence":"additional","affiliation":[{"name":"8ShireLexington, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marelli","sequence":"additional","affiliation":[{"name":"7Shire International GmbHZug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologySahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2017041317200936000_176.6.715.1","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1185\/03007995.2014.925865","article-title":"Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments","volume":"30","author":"Johannsson","year":"2014","journal-title":"Current Medical Research and Opinion"},{"key":"2017041317200936000_176.6.715.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03340.x"},{"key":"2017041317200936000_176.6.715.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0076"},{"key":"2017041317200936000_176.6.715.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03596.x"},{"key":"2017041317200936000_176.6.715.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710"},{"key":"2017041317200936000_176.6.715.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4059"},{"key":"2017041317200936000_176.6.715.7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0023"},{"key":"2017041317200936000_176.6.715.8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.13059","article-title":"Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison\u2019s disease","volume":"85","author":"van der Valk","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2017041317200936000_176.6.715.9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1114"},{"key":"2017041317200936000_176.6.715.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0524"},{"key":"2017041317200936000_176.6.715.11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jc.2015-2853","article-title":"Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the Whitehall II Cohort Study","volume":"101","author":"Hackett","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017041317200936000_176.6.715.12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.physbeh.2015.08.011","article-title":"Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison\u2019s disease","volume":"151","author":"Henry","year":"2015","journal-title":"Physiology and Behavior"},{"key":"2017041317200936000_176.6.715.13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12603"},{"key":"2017041317200936000_176.6.715.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0555"},{"key":"2017041317200936000_176.6.715.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.9.3082"},{"key":"2017041317200936000_176.6.715.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0808180106"},{"key":"2017041317200936000_176.6.715.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3191"},{"key":"2017041317200936000_176.6.715.18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-12-8","article-title":"Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency \u2013 a worldwide patient survey","volume":"12","author":"Forss","year":"2012","journal-title":"BMC Endocrine Disorders"},{"key":"2017041317200936000_176.6.715.19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.12991","article-title":"Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information","volume":"84","author":"Chapman","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2017041317200936000_176.6.715.20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0170"},{"key":"2017041317200936000_176.6.715.21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1212"},{"key":"2017041317200936000_176.6.715.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1926"},{"key":"2017041317200936000_176.6.715.23","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0681-z"},{"key":"2017041317200936000_176.6.715.24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0327"},{"key":"2017041317200936000_176.6.715.25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","article-title":"Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements","volume":"64","author":"Arlt","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"2017041317200936000_176.6.715.26","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.Supplement_1.S79"},{"key":"2017041317200936000_176.6.715.27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7525-4-88","article-title":"Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S)","volume":"4","author":"Grossi","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"2017041317200936000_176.6.715.28","first-page":"379","article-title":"Clinical and immunological characteristics of autoimmune Addison\u2019s disease: a nationwide Swedish multicenter study","volume":"102","author":"Dalin","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017041317200936000_176.6.715.29","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0884"},{"key":"2017041317200936000_176.6.715.30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0559"},{"key":"2017041317200936000_176.6.715.31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus","volume":"32","author":"Iglay","year":"2016","journal-title":"Current Medical Research and Opinion"},{"key":"2017041317200936000_176.6.715.32","first-page":"94","article-title":"Prevalence of hypertension and controlled hypertension \u2013 United States, 2005\u20132008.","volume":"60","author":"Keenan","year":"2011","journal-title":"MMWR Supplement"},{"key":"2017041317200936000_176.6.715.33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.HYP.8.11.1044","article-title":"Age-related changes in blood pressure","volume":"8","author":"Landahl","year":"1986","journal-title":"Hypertension"},{"key":"2017041317200936000_176.6.715.34","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.pmed.1000440","article-title":"Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts","volume":"8","author":"Wills","year":"2011","journal-title":"PLoS Medicine"},{"key":"2017041317200936000_176.6.715.35","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmu048"},{"key":"2017041317200936000_176.6.715.36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0397"},{"key":"2017041317200936000_176.6.715.37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000442985","article-title":"Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial","volume":"103","author":"Werumeus Buning","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2017041317200936000_176.6.715.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2009.12.006"},{"key":"2017041317200936000_176.6.715.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1901"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/6\/715.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-17-0067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:53:42Z","timestamp":1719100422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/176\/6\/715\/6655166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":39,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1530\/eje-17-0067","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}